{"BXP": {"Ticker": "BXP", "Company": "Boston Properties", "Sector": "Real Estate", "Updated": "2023-03-23", "Rating": [{"Date": "2023-03-23", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$57"}, {"Date": "2023-03-21", "Rating": "Resumed", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$56"}, {"Date": "2023-01-04", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$91 to $74"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Goldman", "Deutsche Bank", "Barclays"], "Price_Target": 62.33}, "ISRG": {"Ticker": "ISRG", "Company": "Intuitive Surgical", "Sector": "Health Care", "Updated": "2023-03-23", "Rating": [{"Date": "2023-03-23", "Rating": "Initiated", "Organization": "William Blair", "Rating_Change": "Outperform", "Target_Change": ""}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["William Blair"], "Price_Target": 0}, "MTB": {"Ticker": "MTB", "Company": "M&T Bank", "Sector": "Financials", "Updated": "2023-03-23", "Rating": [{"Date": "2023-03-23", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2023-01-10", "Rating": "Upgrade", "Organization": "Odeon", "Rating_Change": "Hold to Buy", "Target_Change": "$171.76"}, {"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "Wedbush", "Rating_Change": "Neutral to Outperform", "Target_Change": "$170"}, {"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$225 to $194"}], "Score": -0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Wedbush", "Odeon", "Wolfe Research", "Barclays"], "Price_Target": 182.0}, "MRO": {"Ticker": "MRO", "Company": "Marathon Oil", "Sector": "Energy", "Updated": "2023-03-23", "Rating": [{"Date": "2023-03-23", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$27"}, {"Date": "2023-02-16", "Rating": "Upgrade", "Organization": "The Benchmark Company", "Rating_Change": "Hold to Buy", "Target_Change": "$32"}, {"Date": "2023-01-25", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$41"}, {"Date": "2023-01-24", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$27 to $28"}, {"Date": "2023-01-10", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$32"}, {"Date": "2023-01-05", "Rating": "Resumed", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$35"}], "Score": 1.33, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Wells Fargo", "The Benchmark Company", "Citigroup", "Morgan Stanley", "Evercore ISI", "Mizuho"], "Price_Target": 32.5}, "PXD": {"Ticker": "PXD", "Company": "Pioneer Natural Resources", "Sector": "Energy", "Updated": "2023-03-23", "Rating": [{"Date": "2023-03-23", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$193 to $210"}, {"Date": "2023-03-03", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$225 to $220"}, {"Date": "2023-02-27", "Rating": "Upgrade", "Organization": "Tudor, Pickering, Holt & Co.", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2023-01-25", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Underweight", "Target_Change": "$225"}, {"Date": "2023-01-10", "Rating": "Resumed", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$294"}, {"Date": "2023-01-09", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Wells Fargo", "KeyBanc Capital Markets", "Citigroup", "Tudor, Pickering, Holt & Co.", "Mizuho"], "Price_Target": 237.25}, "REG": {"Ticker": "REG", "Company": "Regency Centers", "Sector": "Real Estate", "Updated": "2023-03-23", "Rating": [{"Date": "2023-03-23", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$69 to $70"}, {"Date": "2023-01-06", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$71"}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Robert W. Baird", "Barclays"], "Price_Target": 70.5}, "REGN": {"Ticker": "REGN", "Company": "Regeneron Pharmaceuticals", "Sector": "Health Care", "Updated": "2023-03-23", "Rating": [{"Date": "2023-03-23", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Underperform to Mkt Perform", "Target_Change": ""}, {"Date": "2023-01-30", "Rating": "Upgrade", "Organization": "Cowen", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$775 to $875"}, {"Date": "2023-01-20", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$850"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Raymond James", "JP Morgan", "Cowen"], "Price_Target": 862.5}, "ROP": {"Ticker": "ROP", "Company": "Roper Technologies", "Sector": "Industrials", "Updated": "2023-03-23", "Rating": [{"Date": "2023-03-23", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$475"}, {"Date": "2023-03-22", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Underweight to Neutral", "Target_Change": "$385 to $420"}, {"Date": "2023-03-20", "Rating": "Initiated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$510"}, {"Date": "2023-02-23", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": "$480"}], "Score": 1.25, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Truist", "Mizuho", "Wolfe Research", "JP Morgan"], "Price_Target": 471.25}}